BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6194777)

  • 1. Systemic interferon therapy for multiple sclerosis. Design of a trial.
    Johnson KP
    Arch Neurol; 1983 Oct; 40(11):681-2. PubMed ID: 6194777
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferons and multiple sclerosis.
    Clanet M; Blancher A; Calvas P; Rascol O
    Biomed Pharmacother; 1989; 43(5):355-60. PubMed ID: 2477075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial of natural alpha interferon in multiple sclerosis.
    Knobler RL; Panitch HS; Braheny SL; Sipe JC; Rice GP; Huddlestone JR; Francis GS; Hooper CJ; Kamin-Lewis RM; Johnson KP
    Ann N Y Acad Sci; 1984; 436():382-8. PubMed ID: 6398020
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis.
    Camenga DL; Johnson KP; Alter M; Engelhardt CD; Fishman PS; Greenstein JI; Haley AS; Hirsch RL; Kleiner JE; Kofie VY
    Arch Neurol; 1986 Dec; 43(12):1239-46. PubMed ID: 3535752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal interferon as treatment of multiple sclerosis. A planned multicenter study.
    Jacobs L; O'Malley JA; Freeman A; Reese P
    Arch Neurol; 1983 Oct; 40(11):683-6. PubMed ID: 6354150
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interferon therapy in multiple sclerosis. Mechanism of action, side effects, results].
    Huber M
    Nervenarzt; 1988 Sep; 59(9):514-20. PubMed ID: 2460777
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of multiple sclerosis with various interferons: the cons.
    Johnson KP
    Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon in multiple sclerosis.
    Hendel DL; Hart LL
    DICP; 1990 Feb; 24(2):158-60. PubMed ID: 1689920
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrathecal interferon for multiple sclerosis.
    Berry CC
    Science; 1982 Jul; 217(4556):269-70. PubMed ID: 6178161
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug Insight: interferon treatment in multiple sclerosis.
    Marrie RA; Rudick RA
    Nat Clin Pract Neurol; 2006 Jan; 2(1):34-44. PubMed ID: 16932519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal beta-interferon in multiple sclerosis.
    Milanese C; Salmaggi A; la Mantia L; Corridori F; Nespolo A
    Lancet; 1988 Sep; 2(8610):563-4. PubMed ID: 2900935
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of rat and beta-human interferons on hyperacute experimental allergic encephalomyelitis in rats.
    Hertz F; Deghenghi R
    Agents Actions; 1985 Jul; 16(5):397-403. PubMed ID: 2413742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic alpha-interferon in multiple sclerosis. Long-term patient follow-up.
    Panitch HS
    Arch Neurol; 1987 Jan; 44(1):61-3. PubMed ID: 3800723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal interferon, indomethacin, and multiple sclerosis.
    Berenbaum MC
    Lancet; 1987 Feb; 1(8528):326-7. PubMed ID: 2880135
    [No Abstract]   [Full Text] [Related]  

  • 15. Infectious Diseases Society of America. Trials of interferon therapy for multiple sclerosis.
    Abb J; Deinhardt F; Zander H; Tenser RB; Rapp F; Goust JM; Fudenberg HH; Vilcek J; Ho M; Merigan TC; Oldstone MB; Jackson GG
    J Infect Dis; 1982 Jul; 146(1):109-15. PubMed ID: 6177805
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic interferon therapy of multiple sclerosis: the pros.
    Knobler RL
    Neurology; 1988 Jul; 38(7 Suppl 2):58-61. PubMed ID: 3133575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brief history of the use of interferons as treatment of multiple sclerosis.
    Jacobs L; Johnson KP
    Arch Neurol; 1994 Dec; 51(12):1245-52. PubMed ID: 7986181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New hope for multiple sclerosis victims via an improved, inexpensive, orthomolecular, interferon clinical protocol.
    Stone I
    Australas Nurses J; 1982 Apr; 11(3):13-5. PubMed ID: 6180724
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferons and cancer: how the promise is being kept.
    Borden EC
    Interferon; 1983; 5():43-83. PubMed ID: 6202643
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation.
    Kastrukoff LF; Oger JJ; Hashimoto SA; Sacks SL; Li DK; Palmer MR; Koopmans RA; Petkau AJ; Berkowitz J; Paty DW
    Neurology; 1990 Mar; 40(3 Pt 1):479-86. PubMed ID: 2179764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.